| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |